Hept-3-en-1-ol
General Information
Chemical name | Hept-3-en-1-ol |
CAS number | 10606-47-0 |
COE number | 10219 |
Flavouring type | substances |
FL No. | 02.152 |
Mixture | No |
Purity of the named substance at least 95% unless otherwise specified |
From webgate.ec.europa.eu
Computed Descriptors
Download SDF2D Structure | |
CID | 74363 |
IUPAC Name | hept-3-en-1-ol |
InChI | InChI=1S/C7H14O/c1-2-3-4-5-6-7-8/h4-5,8H,2-3,6-7H2,1H3 |
InChI Key | SDZQUCJFTUULJX-UHFFFAOYSA-N |
Canonical SMILES | CCCC=CCCO |
Molecular Formula | C7H14O |
Wikipedia | (3Z)-3-hepten-1-ol |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 114.188 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 4 |
Complexity | 57.4 |
CACTVS Substructure Key Fingerprint | A A A D c c B g I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A C A C g g A I C A A A A A g C A A C B C A A A A A A A g A A A I C A A A A A g A E A A A A Q A A Q A A A w A A I A A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 20.2 |
Monoisotopic Mass | 114.104 |
Exact Mass | 114.104 |
XLogP3 | None |
XLogP3-AA | 1.9 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 8 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 1 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9446 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7610 |
P-glycoprotein Substrate | Non-substrate | 0.6901 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8789 |
Non-inhibitor | 0.8701 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9080 |
Distribution | ||
Subcellular localization | Lysosome | 0.4428 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7853 |
CYP450 2D6 Substrate | Non-substrate | 0.8919 |
CYP450 3A4 Substrate | Non-substrate | 0.7464 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6264 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9195 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9460 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9196 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9301 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8527 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7315 |
Non-inhibitor | 0.8864 | |
AMES Toxicity | Non AMES toxic | 0.8587 |
Carcinogens | Carcinogens | 0.5564 |
Fish Toxicity | High FHMT | 0.8051 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.5368 |
Honey Bee Toxicity | High HBT | 0.7586 |
Biodegradation | Ready biodegradable | 0.8310 |
Acute Oral Toxicity | III | 0.8324 |
Carcinogenicity (Three-class) | Non-required | 0.6793 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.4186 | LogS |
Caco-2 Permeability | 1.3647 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.6965 | LD50, mol/kg |
Fish Toxicity | 1.9991 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.7898 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty alcohols |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty alcohols |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Fatty alcohol - Organic oxygen compound - Hydrocarbon derivative - Primary alcohol - Organooxygen compound - Alcohol - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty alcohols. These are aliphatic alcohols consisting of a chain of a least six carbon atoms. |
From ClassyFire